These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Electroacupuncture and human iPSC-derived small extracellular vesicles regulate the gut microbiota in ischemic stroke Zhang Q; Deng P; Chen S; Xu H; Zhang Y; Chen H; Zhang J; Sun H Front Immunol; 2023; 14():1107559. PubMed ID: 36742316 [TBL] [Abstract][Full Text] [Related]
4. The Gut Ecosystem: A Critical Player in Stroke. Delgado Jiménez R; Benakis C Neuromolecular Med; 2021 Jun; 23(2):236-241. PubMed ID: 33206321 [TBL] [Abstract][Full Text] [Related]
5. Host-microbiota interactions: The aryl hydrocarbon receptor in the acute and chronic phases of cerebral ischemia. Fan X; Wang S; Hu S; Yang B; Zhang H Front Immunol; 2022; 13():967300. PubMed ID: 36032153 [TBL] [Abstract][Full Text] [Related]
6. Experimental models of focal and multifocal cerebral ischemia: a review. Meadows KL Rev Neurosci; 2018 Aug; 29(6):661-674. PubMed ID: 29397392 [TBL] [Abstract][Full Text] [Related]
8. Crosstalk between the aging intestinal microflora and the brain in ischemic stroke. Pluta R; Jabłoński M; Januszewski S; Czuczwar SJ Front Aging Neurosci; 2022; 14():998049. PubMed ID: 36275012 [TBL] [Abstract][Full Text] [Related]
9. Stroke Literature Synopses: Basic Science. Arai K Stroke; 2015 Dec; 46(12):e250. PubMed ID: 26534972 [No Abstract] [Full Text] [Related]
10. Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke. Vu Q; Xie K; Eckert M; Zhao W; Cramer SC Neurology; 2014 Apr; 82(14):1277-86. PubMed ID: 24610327 [TBL] [Abstract][Full Text] [Related]
11. Remote Ischemic Conditioning as an Additional Treatment for Acute Ischemic Stroke. Landman TRJ; Schoon Y; Warlé MC; de Leeuw FE; Thijssen DHJ Stroke; 2019 Jul; 50(7):1934-1939. PubMed ID: 31154944 [No Abstract] [Full Text] [Related]
14. Mesenchymal Stem Cell Therapy in Ischemic Stroke: A Meta-analysis of Preclinical Studies. Sarmah D; Agrawal V; Rane P; Bhute S; Watanabe M; Kalia K; Ghosh Z; Dave KR; Yavagal DR; Bhattacharya P Clin Pharmacol Ther; 2018 Jun; 103(6):990-998. PubMed ID: 29090465 [TBL] [Abstract][Full Text] [Related]
15. Concise review: Preclinical studies on human cell-based therapy in rodent ischemic stroke models: where are we now after a decade? Leong WK; Lewis MD; Koblar SA Stem Cells; 2013 Jun; 31(6):1040-3. PubMed ID: 23390084 [TBL] [Abstract][Full Text] [Related]
16. Sexual dimorphism in ischemic stroke: lessons from the laboratory. Manwani B; McCullough LD Womens Health (Lond); 2011 May; 7(3):319-39. PubMed ID: 21612353 [TBL] [Abstract][Full Text] [Related]
17. Albumin-Induced Neuroprotection in Focal Cerebral Ischemia in the ALIAS Trial: Does Severity, Mechanism, and Time of Infusion Matter? Khatri R; Afzal MR; Rodriguez GJ; Maud A; Miran MS; Qureshi MA; Cruz-Flores S; Qureshi AI Neurocrit Care; 2018 Feb; 28(1):60-64. PubMed ID: 28439774 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Strategies for Ischemic Stroke-Future Perspectives. Haupt M; Gerner ST; Bähr M; Doeppner TR Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901765 [TBL] [Abstract][Full Text] [Related]
19. Cornuside protects against ischemic stroke in rats by suppressing the IL-17F/TRAF6/NF-κB pathway via the brain-gut axis. Yan C; Liu Z; Xie W; Zhang T; Zhang J; Li G; Xu X; Ye L; Gong J Exp Neurol; 2024 Mar; 373():114672. PubMed ID: 38169196 [TBL] [Abstract][Full Text] [Related]
20. Therapy Effects of Bone Marrow Stromal Cells on Ischemic Stroke. Ye X; Hu J; Cui G Oxid Med Cell Longev; 2016; 2016():7682960. PubMed ID: 27069533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]